Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | Day One Biopharmaceuticals, Inc. | Bender Jeremy
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 7873 | $16.08 - $16.08 | $126,587 |
| 2024-05-16 | Day One Biopharmaceuticals, Inc. | Blackman Samuel C.
(HEAD OF R&D) |
S | Common Stock | D | 2267 | $16.08 - $16.08 | $36,450 |
| 2024-05-16 | Day One Biopharmaceuticals, Inc. | York Charles N II
(COO, CFO AND SECRETARY) |
S | Common Stock | D | 2675 | $16.08 - $16.08 | $43,010 |
| 2024-05-16 | Day One Biopharmaceuticals, Inc. | Dubow Adam
(GENERAL COUNSEL) |
S | Common Stock | D | 3253 | $16.08 - $16.08 | $52,304 |
| 2024-05-10 | Day One Biopharmaceuticals, Inc. | Blackman Samuel C.
(HEAD OF R&D) |
S | Common Stock | D | 10000 | $16.37 - $16.37 | $163,743 |
| 2024-05-01 | Day One Biopharmaceuticals, Inc. | Bender Jeremy
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 79211 | $17.85 - $17.94 | $1,415,706 |
| 2024-05-01 | Day One Biopharmaceuticals, Inc. | York Charles N II
(COO, CFO AND SECRETARY) |
S | Common Stock | D | 60461 | $17.85 - $17.90 | $1,081,190 |
| 2024-04-18 | Day One Biopharmaceuticals, Inc. | Blackman Samuel C.
(HEAD OF R&D) |
S | Common Stock | D | 10000 | $16.02 - $16.02 | $160,163 |
| 2024-03-25 | Day One Biopharmaceuticals, Inc. | Blackman Samuel C.
(HEAD OF R&D) |
S | Common Stock | D | 10000 | $16.01 - $16.01 | $160,055 |
| 2024-02-27 | Day One Biopharmaceuticals, Inc. | Blackman Samuel C.
(HEAD OF R&D) |
S | Common Stock | D | 20000 | $16.11 - $16.11 | $322,166 |
| 2024-02-16 | Day One Biopharmaceuticals, Inc. | Dubow Adam
(GENERAL COUNSEL) |
S | Common Stock | D | 3242 | $15.25 - $15.25 | $49,434 |
| 2024-02-16 | Day One Biopharmaceuticals, Inc. | York Charles N II
(COO, CFO AND SECRETARY) |
S | Common Stock | D | 2666 | $15.25 - $15.25 | $40,651 |
| 2024-02-16 | Day One Biopharmaceuticals, Inc. | Blackman Samuel C.
(HEAD OF RESEARCH AND DEVELOPME) |
S | Common Stock | D | 2258 | $15.25 - $15.25 | $34,430 |
| 2024-02-16 | Day One Biopharmaceuticals, Inc. | Bender Jeremy
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 7615 | $15.25 - $15.25 | $116,114 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |